Harvard Square Advisory Committee
The Harvard Square Advisory Committee reviews applications for variances and special permits within the Harvard Square Overlay District.
Portuguese - Affordable Housing Basics At a Glance
Applying for housing can be confusing and overwhelming. In addition to the information above, there are other programs and housing opportunities that may be available. For more information, please contact the Office of the Housing Liaison at: mpensak@cambridgema.gov
Mass Ave Planning Study Working Group Meeting
Join us as the planning team presents final planning and urban design recommendations for the areas of North Mass Ave and Porter Square to the Mass Ave Planning Study Working Group.
Community Safety Department Development Underway
The City is committed to ensuring the Cambridge community has access to non police responses to crisis situations and creating a sense of safety for all who live, work, play and pray here. The development of the new Community Safety Department is guided by an understanding that a compassionate response to a mental health crisis is optimal for healing and de-escalation.
Danehy Park Improvements Plan Community Meeting #2
Join us for the next community meeting for the Danehy Park Improvements Project! During this session, the project team will share a summary of the community feedback we’ve received so far, discuss project goals and draft ideas inspired by your input. There will be opportunity for breakout discussions for deeper engagement from the community.
Learn to Ride Workshops
The Department of Transportation’s free adult bike workshops help participants build confidence and develop safe riding skills in a supportive environment. Programs include Learn to Bike for beginners, Road Readiness for riders looking to improve their skills, and On-Road Skills for adults interested in gaining confidence riding on city streets. Workshops are free, open to adults, and include the use of bicycles and helmets.
FDA Takes Key Action by Approving Second COVID-19 Vaccine
Today (January 31, 2022), the U.S. Food and Drug Administration approved a second COVID-19 vaccine. The vaccine has been known as the Moderna COVID-19 Vaccine; the approved vaccine will be marketed as Spikevax for the prevention of COVID-19 in individuals 18 years of age and older.